Results 261 to 270 of about 51,657 (292)
Some of the next articles are maybe not open access.

An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016–present)

Expert Opinion on Therapeutic Patents, 2021
Swetha Sanam   +2 more
exaly  

Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot

Reviews in Endocrine and Metabolic Disorders, 2022
Chunlan Zhang, Tian Li, Yang Xiao
exaly  

Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance

Cell, 2016
Bing Cui, Wei Ying, Shuainan Liu
exaly  

Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

International Journal of Molecular Sciences, 2018
Alberto Ricci   +2 more
exaly  

Galectin-3 in Patients with Heart Failure with Preserved Ejection Fraction: Results from the Aldo-DHF Trial

European Journal of Heart Failure, 2015
Carsten Tschope   +2 more
exaly  

Galectin-3 – A jack-of-all-trades in cancer

Cancer Letters, 2011
Lu-Gang Yu
exaly  

Galectin-3 in Cardiovascular Diseases

International Journal of Molecular Sciences, 2020
Umberto Marcello Bracale   +2 more
exaly  

Galectins

2013
Victoria Sundblad   +3 more
openaire   +1 more source

Serum galectin‐1, galectin‐3, and galectin‐9 are bystander molecules for chronic spontaneous urticaria

Allergy, 2019
Lin Zheng   +6 more
openaire   +2 more sources

Galectin-9 in tumor biology: A jack of multiple trades

Biochimica Et Biophysica Acta: Reviews on Cancer, 2013
Vl Thijssen   +2 more
exaly  
galectin-3
cancer
inflammation
previous   25  26  27  28  29  30  

Home - About - Disclaimer - Privacy